Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine PK/PD in Pediatric Anesthesia
NCT02323399Phase 4Recruiting
- Sponsor
- Roxane Laboratories
- Start
- Feb 2015
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phenylephrine in hypotension (6 arms), sponsored by Roxane Laboratories. Primary endpoint: Plasma Phenylephrine (PE) concentrations. Started Feb 2015; status: recruiting.
02
Drugs
phenylephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT02323399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323399.